Osteoporosis Clinical Trials in Philadelphia

Showing 41-52 of 52 trials

Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency

NCT00006394

OBJECTIVES: I. Compare whether the bone tissue in the spine and hip improves in patients with adult onset growth hormone deficiency treated with growth hormone (GH) vs placebo. II. Determine whether the blood samples of these patients show evidence of beneficial bone effects after treatment with GH. III. Compare the quality of life of these patients treated with these 2 regimens. IV. Determine the side effects of GH in these patients.

OsteoporosisGrowth Hormone Deficiency

National Center for Research Resources (NCRR)72 participantsStarted Apr 1997

Boston, Massachusetts, United States • Rochester, Minnesota, United States • St Louis, Missouri, United States +4 more locations

COMPLETEDPhase 336 miles

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

NCT00163137

To compare the effects of 2 years of lasofoxifene treatment with 2 years of raloxifene 60 mg/day use and 2 years of placebo use on bone mineral density (BMD) of the lumbar spine.

Osteoporosis

Ligand Pharmaceuticals540 participantsStarted May 2003

Albany, California, United States • Berkeley, California, United States • La Jolla, California, United States +69 more locations

Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

Osteoporosis Trials in Other Cities

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Other Conditions in Philadelphia